» Articles » PMID: 21343430

The Psychosocial Impact of Epidermolysis Bullosa

Overview
Journal Qual Health Res
Publisher Sage Publications
Specialty Health Services
Date 2011 Feb 24
PMID 21343430
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Epidermolysis bullosa (EB) is a disease in which the skin blisters in response to minimal friction, causing painful wounds. Despite the potentially severe nature of epidermolysis bullosa, research on the psychosocial issues is scarce. The aims of the study were to explore the psychosocial impact of epidermolysis bullosa on affected adults and to identify associated support needs. We collected data using semistructured interviews and employed inductive thematic analysis to organize and analyze them. Three main themes—beliefs about containing the impact of EB, understandings of the disease, and the disabling impact of EB—describe the ways in which living with EB influences the daily lives of participants at intraindividual, interindividual, and sociocultural levels. The associated support needs ranged in type and intensity, from a preference for brief, skills-based interventions and the facilitation of peer support through to longer-term specialist psychological support. The results highlight how the particular combination of the rarity of the disease, its lifelong and hereditary nature, and its disfiguring impact on the skin differentiate epidermolysis bullosa from other chronic conditions.

Citing Articles

Lived experiences of patients with epidermolysis bullosa: A rare genetic skin disease.

Chateau A, Blackbeard D, Aldous C, Dlova N, Shaw C Health SA. 2025; 29():2824.

PMID: 39822893 PMC: 11736545. DOI: 10.4102/hsag.v29i0.2824.


The physical, emotional, social, and functional dimensions of epidermolysis bullosa. An interview study on burdens and helpful aspects from a patients' perspective.

Salamon G, Strobl S, Matschnig M, Diem A Orphanet J Rare Dis. 2025; 20(1):3.

PMID: 39762901 PMC: 11705948. DOI: 10.1186/s13023-024-03475-5.


Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES).

Jeffs E, Pillay E, Ledwaba-Chapman L, Bisquera A, Robertson S, McGrath J Orphanet J Rare Dis. 2024; 19(1):375.

PMID: 39394129 PMC: 11468479. DOI: 10.1186/s13023-024-03349-w.


Facing the complex challenges of people with epidermolysis bullosa in Austria: a mixed methods study on burdens and helpful practices.

Salamon G, Field-Werners U, Strobl S, Hubl V, Diem A Orphanet J Rare Dis. 2024; 19(1):211.

PMID: 38773622 PMC: 11110252. DOI: 10.1186/s13023-024-03163-4.


Factors affecting overall care experience for people living with rare conditions in the UK: exploratory analysis of a quantitative patient experience survey.

Jones J, Cruddas M, Simpson A, Meade N, Pushparajah D, Peter M Orphanet J Rare Dis. 2024; 19(1):77.

PMID: 38373961 PMC: 10877794. DOI: 10.1186/s13023-024-03081-5.